A transcriptional perspective on human macrophage biology

Seminars in Immunology

Volumn 27, Issue 1, 2015, Pages 44-50

  Schultze, Joachim L ^a   Freeman, Tom ^b   Hume, David A ^b   Latz, Eicke ^a,c,d  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Activation; Human; Macrophage; Transcriptome

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTOME;

CELL FUNCTION; EPIGENETICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MACROPHAGE; MACROPHAGE ACTIVATION; MOLECULAR BIOLOGY; NONHUMAN; ORGANIZATION; PATHOLOGY; PHYSIOLOGY; REVIEW; TISSUE METABOLISM; TRANSCRIPTION REGULATION; ANIMAL; GENE EXPRESSION REGULATION; IMMUNOLOGY; INFLAMMATION; METABOLISM;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84928705290     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2015.02.001     Document Type: Review

References (98)

1. Hume D.A. Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunol. 2008, 1:432-441.
2. Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
3. Hume D.A. The mononuclear phagocyte system. Curr. Opin. Immunol. 2006, 18:49-53.
4. Henson P.M., Hume D.A. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 2006, 27:244-250.
5. Riabov V., Gudima A., Wang N., Mickley A., Orekhov A., Kzhyshkowska J. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front. Physiol. 2014, 5:75.
6. Chen P., Bonaldo P. Role of macrophage polarization in tumor angiogenesis and vessel normalization: implications for new anticancer therapies. Int. Rev. Cell Mol. Biol. 2013, 301:1-35.
7. Bird L. Macrophages preventing lipid overload. Nat. Rev. Immunol. 2011, 11:73.
8. Buckley C.D., Gilroy D.W., Serhan C.N. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 2014, 40:315-327.
9. Thorburn A.N., Macia L., Mackay C.R. Diet, metabolites, and western-lifestyle inflammatory diseases. Immunity 2014, 40:833-842.
10. Hill A.A., Reid Bolus W., Hasty A.H. A decade of progress in adipose tissue macrophage biology. Immunol. Rev. 2014, 262:134-152.
11. Habib A., Finn A.V. The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis. Front. Pharmacol. 2014, 5:195.
12. Kohyama M., Ise W., Edelson B.T., Wilker P.R., Hildner K., Mejia C., et al. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 2009, 457:318-321.
13. Jung M., Mertens C., Brune B. Macrophage iron homeostasis and polarization in the context of cancer. Immunobiology 2014.
14. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2001, 2:675-680.
15. Kumar H., Kawai T., Akira S. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 2011, 30:16-34.
16. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
17. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Investig. 2012, 122:787-795.
18. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889-896.
19. Biswas S.K., Mantovani A. Orchestration of metabolism by macrophages. Cell Metab. 2012, 15:432-437.
20. Mantovani A., Sica A., Locati M. Macrophage polarization comes of age. Immunity 2005, 23:344-346.
21. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008, 13:453-461.
22. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
23. Xue J., Schmidt S.V., Sander J., Draffehn A.M., Krebs W., Quester I., et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014, 40:274-288.
24. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
25. Hume D.A. Plenary perspective: the complexity of constitutive and inducible gene expression in mononuclear phagocytes. J. Leukoc. Biol. 2012, 92:433-444.
26. McNelis J.C., Olefsky J.M. Macrophages, immunity, and metabolic disease. Immunity 2014, 41:36-48.
27. Kraakman M.J., Murphy A.J., Jandeleit-Dahm K., Kammoun H.L. Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function?. Front. Immunol. 2014, 5:470.
28. Garg S.K., Delaney C., Shi H., Yung R. Changes in adipose tissue macrophages and T cells during aging. Crit. Rev. Immunol. 2014, 34:1-14.
29. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11:723-737.
30. Swirski F.K., Nahrendorf M. Imaging macrophage development and fate in atherosclerosis and myocardial infarction. Immunol. Cell Biol. 2013, 91:297-303.
31. Parathath S., Yang Y., Mick S., Fisher E.A. Hypoxia in murine atherosclerotic plaques and its adverse effects on macrophages. Trends Cardiovasc. Med. 2013, 23:80-84.
32. Moore K.J., Sheedy F.J., Fisher E.A. Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 2013, 13:709-721.
33. Leitinger N., Schulman I.G. Phenotypic polarization of macrophages in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2013, 33:1120-1126.
34. Van Overmeire E., Laoui D., Keirsse J., Van Ginderachter J.A., Sarukhan A. Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues. Front. Immunol. 2014, 5:127.
35. Noy R., Pollard J.W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014, 41:49-61.
36. Laoui D., Van Overmeire E., De Baetselier P., Van Ginderachter J.A., Raes G. Functional relationship between tumor-associated macrophages and macrophage colony-stimulating factor as contributors to cancer progression. Front. Immunol. 2014, 5:489.
37. Franklin R.A., Liao W., Sarkar A., Kim M.V., Bivona M.R., Liu K., et al. The cellular and molecular origin of tumor-associated macrophages. Science 2014, 344:921-925.
38. Torroella-Kouri M., Rodriguez D., Caso R. Alterations in macrophages and monocytes from tumor-bearing mice: evidence of local and systemic immune impairment. Immunol. Res. 2013, 57:86-98.
39. Squadrito M.L., Etzrodt M., De Palma M., Pittet M.J. MicroRNA-mediated control of macrophages and its implications for cancer. Trends Immunol. 2013, 34:350-359.
40. De Palma M., Lewis C.E. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell. 2013, 23:277-286.
41. Biswas S.K., Allavena P., Mantovani A. Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin. Immunopathol. 2013, 35:585-600.
42. Vlahos R., Bozinovski S. Role of alveolar macrophages in chronic obstructive pulmonary disease. Front. Immunol. 2014, 5:435.
43. Holloway R.A., Donnelly L.E. Immunopathogenesis of chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 2013, 19:95-102.
44. Hiemstra P.S. Altered macrophage function in chronic obstructive pulmonary disease. Ann. Am. Thorac. Soc. 2013, 10 Suppl.:S180-S185.
45. Watters S.A., Mlcochova P., Gupta R.K. Macrophages: the neglected barrier to eradication. Curr. Opin. Infect. Dis. 2013, 26:561-566.
46. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
47. Perry V.H., Holmes C. Microglial priming in neurodegenerative disease. Nat. Rev. Neurol. 2014, 10:217-224.
48. Rivest S. Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 2009, 9:429-439.
49. Heneka M.T., Kummer M.P., Latz E. Innate immune activation in neurodegenerative disease. Nat. Rev. Immunol. 2014, 14:463-477.
50. Perry V.H., Teeling J. Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin. Immunopathol. 2013, 35:601-612.
51. Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012, 13:1118-1128.
52. Hume D.A., Mabbott N., Raza S., Freeman T.C. Can DCs be distinguished from macrophages by molecular signatures. Nat. Immunol. 2013, 14:187-189.
53. Lavin Y., Winter D., Blecher-Gonen R., David E., Keren-Shaul H., Merad M., et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 2014, 159:1312-1326.
54. Perdiguero E.G., Klapproth K., Schulz C., Busch K., Azzoni E., Crozet L., et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 2014, 518:547-551.
55. Ginhoux F., Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 2014, 14:392-404.
56. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
57. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336:86-90.
58. Yona S., Kim K.W., Wolf Y., Mildner A., Varol D., Breker M., et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013, 38:79-91.
59. Davies L.C., Jenkins S.J., Allen J.E., Taylor P.R. Tissue-resident macrophages. Nat. Immunol. 2013, 14:986-995.
60. Jenkins S.J., Hume D.A. Homeostasis in the mononuclear phagocyte system. Trends Immunol. 2014, 35:358-367.
61. Zigmond E., Jung S. Intestinal macrophages: well educated exceptions from the rule. Trends Immunol. 2013, 34:162-168.
62. Molawi K., Wolf Y., Kandalla P.K., Favret J., Hagemeyer N., Frenzel K., et al. Progressive replacement of embryo-derived cardiac macrophages with age. J. Exp. Med. 2014, 211:2151-2158.
63. Hoeffel G., Wang Y., Greter M., See P., Teo P., Malleret B., et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J. Exp. Med. 2012, 209:1167-1181.
64. MacDonald K.P., Palmer J.S., Cronau S., Seppanen E., Olver S., Raffelt N.C., et al. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. Blood 2010, 116:3955-3963.
65. Jenkins S.J., Ruckerl D., Thomas G.D., Hewitson J.P., Duncan S., Brombacher F., et al. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J. Exp. Med. 2013, 210:2477-2491.
66. Gundra U.M., Girgis N.M., Ruckerl D., Jenkins S., Ward L.N., Kurtz Z.D., et al. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood 2014, 123:e110-e122.
67. Lavine K.J., Epelman S., Uchida K., Weber K.J., Nichols C.G., Schilling J.D., et al. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:16029-16034.
68. Schroder K., Irvine K.M., Taylor M.S., Bokil N.J., Le Cao K.A., Masterman K.A., et al. Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E944-E953.
69. Nino-Castro A., Abdullah Z., Popov A., Thabet Y., Beyer M., Knolle P., et al. The IDO1-induced kynurenines play a major role in the antimicrobial effect of human myeloid cells against Listeria monocytogenes. Innate Immun. 2014, 20:401-411.
70. Popov A., Abdullah Z., Wickenhauser C., Saric T., Driesen J., Hanisch F.G., et al. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J. Clin. Investig. 2006, 116:3160-3170.
71. Kapetanovic R., Fairbairn L., Beraldi D., Sester D.P., Archibald A.L., Tuggle C.K., et al. Pig bone marrow-derived macrophages resemble human macrophages in their response to bacterial lipopolysaccharide. J. Immunol. 2012, 188:3382-3394.
72. Smale S.T., Tarakhovsky A., Natoli G. Chromatin contributions to the regulation of innate immunity. Ann. Rev. Immunol. 2014, 32:489-511.
73. Lawrence T., Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 2011, 11:750-761.
74. Natoli G., Monticelli S. Macrophage activation: glancing into diversity. Immunity 2014, 40:175-177.
75. Medzhitov R., Horng T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9:692-703.
76. Edgar R., Domrachve M., Lash A.E. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucl. Acids Res. 2002, 30:207-210.
77. Kolesnikov N., Hastings E., Keays M., Melnichuk O., Tang Y.A., Williams E., et al. ArrayExpress update-simplifying data submissions. Nucl. Acids Res. 2014, 43.
78. Murray P.J., Allen J.E., Biswas S.K., Fisher E.A., Gilroy D.W., Goerdt S., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014, 2014.
79. Doig T.N., Hume D.A., Theocharidis T., Goodlad J.R., Gregory C.D., Freeman T.C. Coexpression analysis of large cancer datasets provides insight into the cellular phenotypes of the tumour microenvironment. BMC Genomics 2013, 14:469.
80. Hume D.A., Freeman T.C. Transcriptomic analysis of mononuclear phagocyte differentiation and activation. Immunol. Rev. 2014, 262:74-84.
81. Fairfax B.P., Humburg P., Makino S., Naranbhai V., Wong D., Lau E., et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 2014, 343:1246949.
82. Mabbott N.A., Baillie J.K., Brown H., Freeman T.C., Hume D.A. An expression atlas of human primary cells: inference of gene function from coexpression networks. BMC Genomics 2013, 14:632.
83. Mabbott N.A., Kenneth Baillie J., Hume D.A., Freeman T.C. Meta-analysis of lineage-specific gene expression signatures in mouse leukocyte populations. Immunobiology 2010, 215:724-736.
84. Andersson R., Gebhard C., Miguel-Escalada I., Hoof I., Bornholdt J., Boyd M., et al. An atlas of active enhancers across human cell types and tissues. Nature 2014, 507:455-461.
85. Yosef N., Shalek A.K., Gaublomme J.T., Jin H., Lee Y., Awasthi A., et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature 2013, 496:461-468.
86. De Nardo D., Labzin L.I., Kono H., Seki R., Schmidt S.V., Beyer M., et al. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3. Nat. Immunol. 2014, 15:152-160.
87. Gilchrist M., Thorsson V., Li B., Rust A.G., Korb M., Roach J.C., et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 2006, 441:173-178.
88. Gold E.S., Ramsey S.A., Sartain M.J., Selinummi J., Podolsky I., Rodriguez D.J., et al. ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation. J. Exp. Med. 2012, 209:807-817.
89. Muller S., Quast T., Schroder A., Hucke S., Klotz L., Jantsch J., et al. Salt-dependent chemotaxis of macrophages. PLoS ONE 2013, 8:e73439.
90. Machnik A., Neuhofer W., Jantsch J., Dahlmann A., Tammela T., Machura K., et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat. Med. 2009, 15:545-552.
91. Delamarre L., Mellman I. Harnessing dendritic cells for immunotherapy. Semin. Immunol. 2011, 23:2-11.
92. Shalek A.K., Satija R., Adiconis X., Gertner R.S., Gaublomme J.T., Raychowdhury R., et al. Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells. Nature 2013, 498:236-240.
93. Shalek A.K., Satija R., Shuga J., Trombetta J.J., Gennert D., Lu D., et al. Single-cell RNA-seq reveals dynamic paracrine control of cellular variation. Nature 2014, 510:363-369.
94. Jaitin D.A., Kenigsberg E., Keren-Shaul H., Elefant N., Paul F., Zaretsky I., et al. Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types. Science 2014, 343:776-779.
95. Kumar R.M., Cahan P., Shalek A.K., Satija R., Jay DaleyKeyser A., Li H., et al. Deconstructing transcriptional heterogeneity in pluripotent stem cells. Nature 2014, 516:56-61.
96. Consortium F., the RP, Clst A promoter-level mammalian expression atlas. Nature 2014, 507:462-470.
97. Schmidl C., Renner K., Peter K., Eder R., Lassmann T., Balwierz P.J., et al. Transcription and enhancer profiling in human monocyte subsets. Blood 2014, 123:90-99.
98. Davis M.M. A prescription for human immunology. Immunity 2008, 29:835-838.